About Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology is a company based in Jing'an (China) founded in 2017 by Junlin Wang. Youlin Pharmaceutical Technology has raised $15.66 million across 1 funding round from investors including Bell Capital and Cenova. Youlin Pharmaceutical Technology offers products and services including Clinical Research Services and Data Management Services.
- Headquarter Jing'an, China
- Founders Junlin Wang
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website union-laboratory.com
- Legal Name 上海有临医药科技有限公司
- Date of Incorporation 10 Aug, 1977
- Jurisdiction Maharashtra, India
- Total Equity Funding$15.66M (USD)
in 1 rounds
- Latest Funding Round$15.66M (USD), Series A
Jun 2021
- InvestorsBell Capital
& 1 more
Associated legal entities of Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology operates through , (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| , CIN U99999MH1977PLC010754 | Active | 10 Aug 1977 | Nanded, Maharashtra | – | – | – | View details |
Products & Services of Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology offers a comprehensive portfolio of products and services, including Clinical Research Services and Data Management Services.
Early and II-III phase clinical trials are conducted for various therapeutic areas
Data management and statistical analysis are provided for clinical trials using tools like TrialMaster
Funding Insights of Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology has successfully raised a total of $15.66M through 1 strategic funding round. The most recent funding activity was a Series A round of $15.66 million completed in June 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.66M
- Total Rounds 1
- Last Round Series A β $15.66M
- First Round $15.66M
(Jun 2021)
- Investors Count 2
All 1 funding rounds of Youlin Pharmaceutical Technology with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun 2021 | $15.66M | Series A | β | Bell Capital |
2 investors in total: 2 institutional.
Investors in Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Bell Capital and Cenova.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
- | – | ebvc.com.cn | - | |
- | – | cenovaventures.com | - |
Investor details for Youlin Pharmaceutical Technology
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Youlin Pharmaceutical Technology
1 people are tracked at Youlin Pharmaceutical Technology (1 in leadership).
| Name | Role | Group |
|---|---|---|
Junlin Wang | Founder & CEO | Leadership |
Complete people profiles for Youlin Pharmaceutical Technology
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Youlin Pharmaceutical Technology
2 dated milestones of Youlin Pharmaceutical Technology across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Youlin Pharmaceutical Technology is founded.
- Funding First funding round of $15.7M.
Similar companies to Youlin Pharmaceutical Technology
10 companies that operate in the same segment as Youlin Pharmaceutical Technology (Clinical Trials & Research Tech), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Genetic services are provided by Colossal's laboratory operations. | 2021 | Austin, Texas, United States | USD 617.6 M | – | – | |
Research lab engaged in pharmacological measurements on therapeutic protein variants | 2018 | United States | USD 78.19 M | – | 22 | |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare. | 2004 | Ahmedabad, Gujarat, India | – | USD 50.52 M | 902 | |
Generic injectables for oncology and anesthesiology are manufactured. | 1989 | Hyderabad, Telangana, India | – | USD 4.22 M | 228 | |
Medical research labs are provided by GALY for scientific purposes. | 2018 | Boston, Massachusetts, United States | USD 61.59 M | – | 25 | |
Laboratory focused on biotechnology & molecule research services | 2018 | Cambridge, Massachusetts, United States | USD 32.68 M | – | – | |
Laboratory delivers discovery & research in nuclear and particle physics | 1947 | United States | – | – | 2,436 | |
Research and manufacturing of hemp products are conducted by BRC. | 2017 | Monterey, California, United States | USD 25.26 M | – | 16 | |
Genome sequencing studies are conducted for medical research purposes. | 2020 | Cambridge, Cambridgeshire, United Kingdom | USD 11.26 M | – | 12 | |
Novel immunotherapy therapeutic targets are discovered through laboratory research. | 2019 | Branford, Connecticut, United States | USD 92 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Youlin Pharmaceutical Technology
Youlin Pharmaceutical Technology was founded in 2017 and raised its 1st funding round 4 years after it was founded.
Youlin Pharmaceutical Technology is headquartered in Jing'an, China. It is registered at Jing'an, Shanghai, China.
Junlin Wang is the current CEO of Youlin Pharmaceutical Technology. They have also founded this company.
Youlin Pharmaceutical Technology is a funded company, having raised a total of $15.66M across 1 funding round to date. The company's 1st funding round was a Series A of $15.66M, raised on Jun 2021.
Youlin Pharmaceutical Technology laboratory focused on providing diversified services for development of innovative oncology drugs through providing healthcare solutions, and medical research labs. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Youlin Pharmaceutical Technology offers Clinical Research Services and Data Management Services.
Youlin Pharmaceutical Technology has 2 investors. Key investors include Bell Capital, and Cenova.
Youlin Pharmaceutical Technology operates through ,.